An N6-methyladenosine and target genes-based study on subtypes and prognosis of lung adenocarcinoma

被引:1
|
作者
Chu, Xiao [1 ]
Wang, Weiqing [1 ]
Sun, Zhaoyun [1 ]
Bao, Feichao [2 ]
Feng, Liang [1 ]
机构
[1] Fudan Univ, Peoples Hosp Shanghai 5, Dept Thorac Surg, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Thorac Surg, Affiliated Chest Hosp, Shanghai, Peoples R China
关键词
N-6-methyladenosine (m(6)A); consensus clustering; prognostic score; immune cells; nomogram; TUMOR; EXPRESSION; CELLS; E2F7;
D O I
10.3934/mbe.2022013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: Lung adenocarcinoma (LUAD) is a highly lethal subtype of primary lung cancer with a poor prognosis. N6-methyladenosine (m(6)A), the most predominant form of RNA modification, regulates biological processes and has critical prognostic implications for LUAD. Our study aimed to mine potential target genes of m(6)A regulators to explore their biological significance in subtyping LUAD and predicting survival. Methods: Using gene expression data from TCGA database, candidate target genes of m(6)A were predicted from differentially expressed genes (DEGs) in tumor based on M(6)A2 Target database. The survival-related target DEGs identified by Cox-regression analysis was used for consensus clustering analysis to subtype LUAD. Uni-and multi-variable Cox regression analysis and LASSO Cox-PH regression analysis were used to select the optimal prognostic genes for constructing prognostic score (PS) model. Nomogram encompassing PS score and independent prognostic factors was built to predict 3-year and 5-year survival probability. Results: We obtained 2429 DEGs in tumor tissue, within which, 1267 were predicted to m(6)A target genes. A prognostic m(6)A-DEGs network of 224 survival-related target DEGs was established. We classified LUAD into 2 subtypes, which were significantly different in OS time, clinicopathological characteristics, and fractions of 12 immune cell types. A PS model of five genes (C1QTNF6, THSD1, GRIK2, E2F7 and SLCO1B3) successfully split the training set or an independent GEO dataset into two subgroups with significantly different OS time (p < 0.001, AUC = 0.723; p = 0.017, AUC = 0.705).A nomogram model combining PS status, pathologic stage, and recurrence was built, showing good performance in predicting 3-year and 5-year survival probability (C-index = 0.708, 0.723, p-value = 0). Conclusion: Using candidate m(6)A target genes, we obtained two molecular subtypes and designed a reliable five-gene PS score model for survival prediction in LUAD.
引用
收藏
页码:253 / 270
页数:18
相关论文
共 50 条
  • [31] Identification of marker genes associated with N6-methyladenosine and autophagy in ulcerative colitis
    Liu, Xiao-Yan
    Qiao, Dan
    Zhang, Ya-Li
    Liu, Zi-Xuan
    Chen, You-Lan
    Que, Ren-Ye
    Cao, Hong-Yan
    Dai, Yan-Cheng
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (10)
  • [32] Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease
    Qin, Lixia
    Min, Shishi
    Shu, Li
    Pan, Hongxu
    Zhong, Junfei
    Guo, Jifeng
    Sun, Qiying
    Yan, Xinxiang
    Chen, Chao
    Tang, Beisha
    Xu, Qian
    NEUROBIOLOGY OF AGING, 2020, 93 : 143.e9 - 143.e13
  • [33] Recognition of the Subtypes Classification and Diagnostic Signature Based on RNA N6-Methyladenosine Regulators in Recurrent Spontaneous Abortion
    Zitao Wang
    Fangfang Dai
    Hua Liu
    Yanxiang Cheng
    Reproductive Sciences, 2023, 30 : 3537 - 3547
  • [34] Genes associated with N6-methyladenosine regulators provide insight into the prognosis and immune response to renal clear cell carcinoma
    Fan, Guobin
    Wu, Dejun
    Chen, Huaping
    Wen, Zhi
    Liao, Linhui
    He, Shuming
    Yang, Jie
    ENVIRONMENTAL TOXICOLOGY, 2024, 39 (02) : 626 - 642
  • [35] Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
    Zhu, Qianru
    Huang, Xingxing
    Yu, Shuxian
    Shou, Lan
    Zhang, Ruonan
    Xie, Han
    Liang, Zimao
    Sun, Xueni
    Feng, Jiao
    Duan, Ting
    Zhang, Mingming
    Xiang, Yu
    Sui, Xinbing
    Jin, Weiwei
    Yu, Lili
    Wu, Qibiao
    FRONTIERS IN GENETICS, 2022, 13
  • [36] Recognition of the Subtypes Classification and Diagnostic Signature Based on RNA N6-Methyladenosine Regulators in Recurrent Spontaneous Abortion
    Wang, Zitao
    Dai, Fangfang
    Liu, Hua
    Cheng, Yanxiang
    REPRODUCTIVE SCIENCES, 2023, 30 (12) : 3537 - 3547
  • [37] N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes
    Wei, Jie
    Fang, Da Lang
    Zhou, Weijie
    He, Yong Fei
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (04) : 1860 - 1872
  • [38] N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy
    Zhang, Meng-Meng
    Lin, Yi-Lin
    Zeng, Wen-Feng
    Li, Yang
    Yang, Yang
    Liu, Miao
    Ye, Ying-Jiang
    Jiang, Ke-Wei
    Wang, Shu
    Wang, Shan
    FRONTIERS IN GENETICS, 2021, 12
  • [39] N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
    Xu, Hao
    Yin, Lu
    Xu, Qianhui
    Xiang, Jingjing
    Xu, Rujun
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [40] IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
    Xu, Xin
    Cui, Jiangtao
    Wang, Hong
    Ma, Lifang
    Zhang, Xiao
    Guo, Wanxin
    Xue, Xiangfei
    Wang, Yikun
    Qiu, Shiyu
    Tian, Xiaoting
    Miao, Yayou
    Wu, Mengyi
    Yu, Yongchun
    Xu, Yunhua
    Wang, Jiayi
    Qiao, Yongxia
    MATERIALS TODAY BIO, 2022, 17